Literature DB >> 1333745

Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.

A Mygland1, O B Tysnes, R Matre, P Volpe, J A Aarli, N E Gilhus.   

Abstract

Sera from patients with myasthenia gravis were examined by Western blot for the presence of antibodies to proteins of the sarcoplasmic reticulum from rabbit skeletal muscle. Fourteen of 30 patients with myasthenia gravis and a thymoma had IgG autoantibodies to the calcium release channel of the sarcoplasmic reticulum (the ryanodine receptor), which plays a crucial role in the mechanism of excitation-contraction coupling in striated muscle. Ryanodine receptor autoantibodies were not detected in any of the 45 sera from patients with myasthenia gravis without a thymoma. Ryanodine receptor autoantibodies may have pathogenetic relevance in thymoma-associated myasthenia gravis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1333745     DOI: 10.1002/ana.410320419

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  13 in total

1.  Morvan's fibrillary chorea: a paraneoplastic manifestation of thymoma.

Authors:  E K Lee; R A Maselli; W G Ellis; M A Agius
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-12       Impact factor: 10.154

Review 2.  Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review.

Authors:  Jayne L Chamberlain; Saif Huda; Daniel H Whittam; Marcelo Matiello; B Paul Morgan; Anu Jacob
Journal:  J Neurol       Date:  2019-09-03       Impact factor: 4.849

3.  Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.

Authors:  A Mygland; J A Aarli; R Matre; N E Gilhus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-07       Impact factor: 10.154

4.  Three types of striational antibodies in myasthenia gravis.

Authors:  Shigeaki Suzuki; Kimiaki Utsugisawa; Yuriko Nagane; Norihiro Suzuki
Journal:  Autoimmune Dis       Date:  2011-07-17

5.  Cytometric cell-based assays for anti-striational antibodies in myasthenia gravis with myositis and/or myocarditis.

Authors:  Kenji Kufukihara; Yurika Watanabe; Takashi Inagaki; Koutaro Takamatsu; Shunya Nakane; Jin Nakahara; Yukio Ando; Shigeaki Suzuki
Journal:  Sci Rep       Date:  2019-03-27       Impact factor: 4.379

Review 6.  Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture.

Authors:  Inga Koneczny; Ruth Herbst
Journal:  Cells       Date:  2019-07-02       Impact factor: 6.600

7.  A Spectrum of Neural Autoantigens, Newly Identified by Histo-Immunoprecipitation, Mass Spectrometry, and Recombinant Cell-Based Indirect Immunofluorescence.

Authors:  Madeleine Scharf; Ramona Miske; Stephanie Kade; Stefanie Hahn; Yvonne Denno; Nora Begemann; Nadine Rochow; Christiane Radzimski; Stephanie Brakopp; Christian Probst; Bianca Teegen; Winfried Stöcker; Lars Komorowski
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

Review 8.  Autoantibody Specificities in Myasthenia Gravis; Implications for Improved Diagnostics and Therapeutics.

Authors:  Konstantinos Lazaridis; Socrates J Tzartos
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

Review 9.  Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology.

Authors:  Miriam L Fichtner; Ruoyi Jiang; Aoibh Bourke; Richard J Nowak; Kevin C O'Connor
Journal:  Front Immunol       Date:  2020-05-27       Impact factor: 7.561

10.  Myasthenia Gravis: From the Viewpoint of Pathogenicity Focusing on Acetylcholine Receptor Clustering, Trans-Synaptic Homeostasis and Synaptic Stability.

Authors:  Masaharu Takamori
Journal:  Front Mol Neurosci       Date:  2020-05-28       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.